Clinical Trial

Long-term Safety & Performance of REVISYON SDS100 in Mild to Moderate Cataract: Extension Study (EB-CE-02)

Study acronym: EB-CE-02
Enrolling by Invitation
View on ClinicalTrials.gov →
Record status
This record was last updated November 24, 2025 (before its estimated December 15, 2025 completion). Its status may not reflect the trial's current state.
Summary
A non-interventional, extension study on the long-term maintenance of safety and performance of the REVISYON SDS 100 medical device in subjects with mild-to-moderate cataract.
Trial Details
NCT Number NCT07246915
Lead Sponsor Edinburgh Biosciences Ltd
Collaborators: MDX Research
Conditions Age-related Cataract, Vision Loss, Cataract, Mild Cataract, Moderate Cataract
Enrollment 61 participants
Start Date 2025-10-28
Primary Completion 2025-12-15 (estimated)
Study Completion 2025-12-15 (estimated)
Updated on ClinicalTrials.gov 2025-11-24